{"schema_version":"secwatch.filing_event.v1","accession":"0001753926-24-000721","form_type":"8-K","ticker":"LIPO","cik":"0001347242","company_name":"LIPELLA PHARMACEUTICALS INC.","filed_at":"2024-04-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.041539+00:00","generated_at":"2026-06-03T23:17:29.233765+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Lipella eliminates Series A Preferred Stock designation after all shares converted to common","bullets":["Filed Series A Elimination Certificate with Delaware Secretary of State on April 11, 2024.","All previously issued Series A Preferred Stock converted into common stock; no shares outstanding.","No further shares will be issued under the Series A designation.","Certificate became effective immediately upon filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001753926-24-000721","json":"https://secwatch.observer/filing/0001753926-24-000721.json","markdown":"https://secwatch.observer/filing/0001753926-24-000721.md","text":"https://secwatch.observer/filing/0001753926-24-000721.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1347242/000175392624000721/0001753926-24-000721-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1347242/000175392624000721/g084176_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T23:17:29.233765+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"70bbb6adb9127d56ac863a30634ca29944001179","claim":"LIPELLA PHARMACEUTICALS INC.: Eliminated and canceled all designations, rights, preferences and limitations of Series A Preferred Stock (effective 2024-04-11).","evidence_excerpt":"On April 11, 2024, the Company filed an Elimination of Certificate of Designation of the Preferences, Rights and Limitations of Series A Preferred Stock (the “Series A Elimination Certificate”) with the Secretary of State of the State of Delaware, in order to eliminate and cancel all designations, rights, preferences and limitations of the shares of the Company’s Series A convertible preferred stock, par value $0.0001 per share (the “Series A Preferred Stock”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1347242/000175392624000721/0001753926-24-000721-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2024-04-11"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}